The OTC dry eye drops market in North America is expected to show steady growth due to the increasing prevalence of dry eye syndrome in the region. The United States and Canada are the major markets in North America, with a high adoption rate of OTC dry eye drops among the aging population. Factors such as technological advancements, easy availability, and affordability of OTC dry eye drops are driving the market growth in this region.
Asia Pacific:
The Asia Pacific OTC dry eye drops market is anticipated to witness rapid growth, primarily driven by the growing awareness about eye health and the rising incidence of dry eye syndrome in countries such as China, Japan, and South Korea. The increasing geriatric population and changing lifestyle habits are also contributing to the market growth in the region. Additionally, the expanding distribution network and increasing disposable income are further boosting the demand for OTC dry eye drops in Asia Pacific.
Europe:
In Europe, countries like the United Kingdom, Germany, and France are expected to be key players in the OTC dry eye drops market. The increasing prevalence of dry eye syndrome, along with the high adoption rate of OTC medications, is propelling the market growth in this region. Moreover, the presence of major market players and ongoing research and development activities are anticipated to drive the market further in Europe.